Dr. Tesser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9520 W Palm Ln
Ste 220
Phoenix, AZ 85037Phone+1 480-443-8400Fax+1 480-443-8697
Education & Training
- Wake Forest University Baptist Medical CenterFellowship, Rheumatology, 1982
- Creighton University School of Medicine/Maricopa Medical Center (Phoenix)Residency, Internal Medicine, 1977 - 1980
- University of Rochester School of Medicine and DentistryClass of 1977
Certifications & Licensure
- AZ State Medical License 1979 - 2025
- NC State Medical License 1980 - 1984
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Top Doctors:Arizona State Castle Connolly, 2013
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2012
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis Start of enrollment: 2015 Feb 21
Publications & Presentations
PubMed
- 6 citationsA Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Rece...John K Botson, Kenneth Saag, Jeff Peterson, Katie Obermeyer, Yan Xin
ACR Open Rheumatology. 2023-08-01 - 285 citationsAnakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-co...Roy M. Fleischmann, Joy Schechtman, Ralph Bennett, Malcolm L. Handel, Gerd-Rüdiger Burmester
Arthritis and Rheumatism. 2003-04-01 - 39 citationsRheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentr...Michael Schiff, Johannes von Kempis, Ronald Goldblum, John Tesser, Ruediger B Mueller
Annals of the Rheumatic Diseases. 2014-12-01
Press Mentions
- Tactics for Bolstering the Rheumatology WorkforceFebruary 13th, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: